CClinicalTrials.gg
CompletedNCT03819257Updated Feb 25, 2020

Anorectal Function in Perianal Crohn's Disease

An observational study in Crohn Disease, sponsored by The Leeds Teaching Hospitals NHS Trust. Completed at 1 site in United Kingdom. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2020-02-25.

Sponsored by The Leeds Teaching Hospitals NHS Trust · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
16
Ages
18 Years to 75 Years
Sex
All
01

Study summary

Perianal Crohn's disease is a disabling disease associated with increased morbidity and impaired quality of life. It is associated with pain, discharge, fecal incontinence and sexual and psychological impairment. In refractory cases, a stoma may be necessary. A higher prevalence is seen with increasing Crohn's disease duration and appears to vary according to the disease location. The presence of symptoms associated with anorectal dysfunction, such as fecal incontinence, can sometimes poorly correlate with the presence of anal sphincter abnormalities. Moreover, even in patients without symptoms, the presence of anal sphincter abnormalities may have important implications for the future selection of type of delivery, and might even pose a contra-indication for certain types of anorectal surgeries.

Studies evaluating possible chronic complications of perianal Crohn's disease on anorectal function are lacking. There is a need for a better understanding of the chronic complications of this disease, and the role of high-resolution anorectal manometry in diagnosing these abnormalities during follow-up of these patients. This study will evaluate the chronic repercussions of perianal Crohn's disease in patients with a previous anal fistula and/or abscess that has healed and/or is inactive.

02

Conditions studied

  • Crohn Disease

Browse trials for

03

In context

Crohn Disease

1,880 studies on the registry are indexed under Crohn Disease; 462 are open to participants now.

This study's enrollment of 16 is below the median of 162 across 608 observational studies indexed under Crohn Disease.

Browse Crohn Disease studies →

Lead sponsor

The Leeds Teaching Hospitals NHS Trust is the lead sponsor of 95 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients attending hospital with diagnosed perianal Crohn's disease.

Inclusion criteria

  1. ≥ 18 and ≤ 75 year-old patients
  2. CD in clinical remission, defined by a Harvey-Bradshaw index \<5
  3. Perianal CD history, defined by the presence of a perianal fistula and/or abscess that were treated/heal/inactive
  4. Perianal Disease Activity Index (PDAI) of ≤4
  5. Asymptomatic or symptomatic patients (anorectal symptoms) will be included, as long they fulfill the other inclusion criteria, like for anorectal symptomatic patients having a PDAI≤4
  6. Endoanal ultrasound without an image compatible with new/non-treated abscess or perianal fistula
  7. Both previous simple or complex perianal fistula (according to the American College of Gastroenterology) will be considered.

Exclusion criteria

Exclusion Criteria:

  1. Women with previous vaginal delivery
  2. Ileostomy
  3. Previous anorectal surgery as hemorrhoidectomy or lateral sphincterotomy
  4. Active rectal disease. No rectal involvement will be defined by no previous rectal involvement ever described or if previous involvement, endoscopy within 18 months showing no current involvement
  5. Previous or current anal fissure
  6. Anal stricture
  7. Current or previous rectovaginal fistula (previous/last pelvic MRI).

A previous seton placement, abscess drainage, fistulotomy and lay open fistula are not an exclusion criteria. Patients with a current seton can only be included if the seton was place more than 24 weeks ago, and the endoanal ultrasound does not show any new/non-treated perianal fistula/abscess.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
16 participants (actual)
Patient registry
No

Groups and cohorts

  • Patients with perianal Crohn's disease.

    Diagnostic Test: Endoanal ultrasound · Diagnostic Test: High-resolution anorectal manometry · Diagnostic Test: Balloon expulsion test

Interventions

  • Diagnostic testEndoanal ultrasound

    For the assessment of the internal and external anal sphincter integrity. To evaluate fistulas/perianal abscess and seton placement.

  • Diagnostic testHigh-resolution anorectal manometry

    1. rest - basal anal pressures at rest over 60 s 2. squeeze - anal pressure during voluntary effort; long squeeze - anal pressure during sustained voluntary effort 3. cough - anorectal pressure changes during cough 4. push - anorectal pressure changes during simulated defecation 5. rectoanal inhibitory reflex - reflex anal response to rectal distension 6. rectal sensation - assessment of rectal sensitivity to distension.

  • Diagnostic testBalloon expulsion test

    A non-latex balloon will be inserted in the rectum after applying lubricating gel. This balloon is then filled with 50ml of warm water. The patient is ask to sit on a commode and to try to expel the device in privacy, while the time is being recorded. The test ends when the patient expelled the balloon or when 3 minutes are reach.

06

What researchers measure

Primary outcomes

  1. Resting pressure, squeezing pressure, anorectal pressure changes during cough, anorectal pressure changes during simulated defecation, presence of a rectoanal inhibitory reflex and assessment of rectal sensitivity to distension.

    Evaluated by high-resolution anorectal manometry.

    Time frame: 30 minutes

  2. Anal sphincters integrity.

    Evaluated by endoanal ultrasound.

    Time frame: 5 minutes

  3. Ballon expulsion test duration.

    Time frame: 3 minutes

Secondary outcomes

  1. Presence of symptoms suggesting obstructed defection.

    Prolonged and unsuccessful straining at stool, self-digitation for defecation, sense of incomplete evacuation or sensation of anorectal obstruction/blockage and a stool frequency of less than three times per week.

    Time frame: 5 minutes

Other outcomes

  1. Wexner score (fecal incontinence score).

    5 items score, including solid, liquid, gas incontinence, wearing pads and lifestyle alterations, scored from 0 (normal) to 4 (more severe).

    Time frame: 5 minutes

07

Study locations

1 site
  • Leeds Teaching Hospital NHS Trust
    Leeds, LS7 4SA, United Kingdom
08

References and documents

Publications

  • Albuquerque A, Casey J, Fairlamb G, Houghton LA, Selinger C. Evaluation of Anorectal Function in Perianal Crohn's Disease: A Pilot Study. J Clin Med. 2021 Dec 16;10(24):5909. doi: 10.3390/jcm10245909. PubMed 34945205 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 25, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03819257
Lead sponsor
The Leeds Teaching Hospitals NHS Trust
Responsible party
Sponsor
First posted
Jan 28, 2019
Start date
Jan 19, 2019
Primary completion
Feb 22, 2020
Completion
Feb 22, 2020
Last update
Feb 25, 2020

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion